Stock listing

LS Exchange:A2PH5P TransMedics Group, Inc. Aktie

German listing (LS Exchange) of TransMedics Group, Inc. · home listing NASDAQ:TMDX

Follow TransMedics Group, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:TMDX

$85.25 USD -11.18 (-11.6%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:TMDX

Past year -31.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$83.89 – $91.62 USDNov 20, 2026
Volume
1.59M sharesNov 20, 2026
Market cap
$2.96B USDAt the close on Nov 20, 2026 · price × 34.73M shares outstanding
52-week range
$60.11 – $156.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$75.62M USDMedian day 789,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
TransMedics Group, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:TMDX · Home$85.25 USD-11.18 (-11.6%)1,587,314$91.62$91.62$83.89$96.43Close on Nov 20, 2026
Frankfurt:8T8€83.34 EUR-3.74 (-4.3%)—€84.30€84.30€83.34€87.08Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:TMDX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$85.25-11.18-11.6%$91.62$91.62$83.891,587,314
$96.43+2.52+2.7%$93.89$98.78$93.521,073,665
$93.91+1.70+1.8%$91.73$95.60$91.32959,439
$92.21+0.83+0.9%$90.60$92.99$89.50564,120
$91.38-0.62-0.7%$92.39$94.28$91.17840,032
$92.00-0.010.0%$91.65$96.46$91.191,052,710
$92.01+1.065+1.2%$90.95$93.45$90.00913,847
$90.95-2.845-3.0%$93.50$97.55$89.491,626,329
$93.79+5.55+6.3%$88.00$95.30$87.222,065,716
$88.24+19.26+27.9%$79.12$88.44$76.503,951,400
$68.98-3.775-5.2%$72.49$73.61$67.331,692,300
$72.76+5.415+8.0%$69.97$74.67$68.672,471,100
$67.34+0.67+1.0%$66.90$68.82$66.36704,700
$66.67+0.68+1.0%$66.47$68.66$65.84689,500
$65.99-1.13-1.7%$67.59$67.75$64.64898,500
$67.12+0.22+0.3%$67.09$69.02$65.52990,900
$66.90-2.83-4.1%$69.02$69.98$66.681,180,500
$69.73-0.90-1.3%$70.53$71.18$69.63826,400
$70.63-0.11-0.2%$70.01$71.97$69.61847,600
$70.74-1.32-1.8%$71.42$72.68$69.76789,700
$72.06-0.34-0.5%$72.34$73.66$70.52627,700
$72.40-2.35-3.1%$74.47$76.00$72.26685,500
$74.75+3.15+4.4%$71.65$75.66$67.311,172,800
$71.60+0.82+1.2%$71.16$72.81$70.50656,800
$70.78-5.74-7.5%$76.52$76.52$70.031,068,000
$76.52+1.00+1.3%$74.41$77.34$74.411,132,500
$75.52-3.615-4.6%$78.20$78.36$74.84891,400
$79.14+0.965+1.2%$78.17$80.42$77.861,025,900
$78.17+0.30+0.4%$77.69$78.50$77.14491,700
$77.87-1.13-1.4%$79.13$81.35$76.86733,700
$79.00-2.07-2.6%$80.25$80.28$77.50949,400
$81.07+0.79+1.0%$80.96$83.90$80.56962,600
$80.28-2.71-3.3%$83.87$84.05$80.08570,700
$82.99+3.195+4.0%$79.50$83.40$77.37994,900
$79.80+1.155+1.5%$79.81$80.85$77.141,223,300
$78.64-4.81-5.8%$83.92$84.24$78.02880,100
$83.45-0.62-0.7%$84.87$84.87$81.55566,600
$84.07+1.34+1.6%$82.56$84.22$81.76440,200
$82.73-2.56-3.0%$86.38$86.38$82.70422,500
$85.29+1.39+1.7%$83.50$85.69$81.80696,700
$83.90-3.10-3.6%$86.09$86.09$82.53623,700
$87.00-1.07-1.2%$88.22$89.19$85.07615,600
$88.07+0.78+0.9%$88.15$89.80$86.50750,700
$87.29+0.87+1.0%$87.35$89.53$86.75590,800
$86.42-0.24-0.3%$87.18$87.98$85.011,441,700
$86.66-0.90-1.0%$88.00$89.41$85.47690,600
$87.56-0.53-0.6%$88.17$88.28$86.29464,700
$88.09+2.23+2.6%$86.39$90.67$85.47942,800
$85.86+3.68+4.5%$82.62$88.49$80.59942,900
$82.18-2.86-3.4%$85.36$86.00$79.231,247,000
$85.04-1.36-1.6%$85.27$87.55$83.69590,900
$86.40-1.87-2.1%$87.47$87.71$84.87665,100
$88.27-1.71-1.9%$89.14$89.55$86.15594,500
$89.98+3.00+3.4%$84.63$90.11$83.61542,600
$86.98+2.69+3.2%$85.72$87.55$84.60574,800
$84.29+2.05+2.5%$82.23$85.52$82.23589,600
$82.24-2.63-3.1%$85.84$86.00$81.34883,900
$84.87-3.56-4.0%$87.65$88.00$82.551,184,100
$88.43-3.32-3.6%$91.90$93.45$88.37630,900
$91.75-0.47-0.5%$91.59$94.24$91.13417,800
$92.22-1.38-1.5%$92.26$93.16$90.24448,800
$93.600.000.0%$93.62$94.33$91.50405,438
$93.60-1.17-1.2%$94.07$94.52$92.04770,374
$94.77+3.92+4.3%$91.11$95.18$90.45627,100
$90.85-3.12-3.3%$92.88$94.30$90.64589,300
Ticker
LS Exchange:A2PH5P
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All TransMedics Group, Inc. news

TransMedics Group, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
22 in the last 12 months · 139 in all · newest Nov 5, 2026 · oldest 2019
Calls
24 calls with a replay · 24 with a transcript · latest Nov 5, 2026
Decks
7 decks · latest September 2026

Where TransMedics Group, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TMDX · Home listingNASDAQUnited StatesUSD
gettex:8T8gettexGermanyEUR
BMV:TMDXBMVMexicoMXN
LS Exchange:A2PH5P · This pageLS ExchangeGermanyEUR
Tradegate:8T8TradegateGermanyEUR
Lang & Schwarz:A2PH5PLang & SchwarzGermanyEUR
BOATS:TMDXBOATSUnited StatesUSD
Milan:1TMDXMilanItalyEUR
BIVA:TMDXBIVAMexicoMXN
BX Swiss:TMDXBX SwissSwitzerlandCHF
Frankfurt:8T8FrankfurtGermanyEUR
Hamburg:8T8HamburgGermanyEUR
Stuttgart:8T8StuttgartGermanyEUR
Dusseldorf:8T8DusseldorfGermanyEUR
Munich:8T8MunichGermanyEUR
Hanover:8T8HanoverGermanyEUR
Xetra:8T8XetraGermanyEUR

Valuation

P/E 20.5× against a median of 31.2×: the lowest of 7 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$2.52B USD
P/E
20.5×
EV/sales
3.5×
EV/EBITDA
19.8×
Price/book
5.4×
Gross margin
58.6%
Operating margin
11.9%
Net margin
19.9%
Debt to equity
0.1×
Beta vs S&P 500
1.31

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
TransMedics Group, Inc. · NASDAQ:TMDXUS$2.96BUS$2.52B20.5×3.5×19.8×5.4×19.9%0.1×1.31
Pulse Biosciences, Inc · NASDAQ:PLSEUS$3.35BUS$3.17Bn/a2,120×n/a18.3×n/a0.0×1.54
Axogen, Inc. · NASDAQ:AXGNUS$3.33BUS$2.98Bn/a11.2×n/a6.7×−12.0%0.0×0.98
Zhende Medical Co., Ltd. Class A · SSE:603301US$3.23BUS$3.13B73.1×4.5×n/a3.8×6.3%0.1×n/a
Lepu Medical Technology (Beijing) Co., Ltd. Class A · SZSE:300003US$3.10BUS$3.03B31.4×3.3×n/a1.3×10.7%0.2×n/a
Carl Zeiss Meditec AG · XETR:AFXUS$3.06BUS$3.06B23.9×1.1×n/a1.3×4.4%0.0×n/a
Imricor Medical Systems, Inc. · ASX:IMRUS$3.00BUS$2.96Bn/a9,794×n/a103×n/a1.2×n/a
Ambu A/S Class B · OMXCOP:AMBU_BUS$2.92BUS$2.92B30.9×3.1×15.9×3.2×9.9%0.1×n/a
AtriCure, Inc. · NASDAQ:ATRCUS$2.82BUS$2.69B190×4.6×75.2×5.3×2.5%0.1×0.58
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H · HKEX:2252US$2.77BUS$2.74Bn/a33.1×n/a44.9×−45.3%1.0×n/a
Ottobock SE & Co. KGaA · XETR:OBCKUS$2.65BUS$3.54B26.8×1.9×8.0×6.1×5.4%2.3×n/a
Median of the othersUS$3.03BUS$3.01B31.2×4.5×15.9×5.7×4.9%0.1×0.98

Forecasts

6 strong buy · 3 buy · 4 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
105.45 USD · Analysts' mean
EPS, year to Dec 2026
1.67 · 10 analysts
Revenue, year to Dec 2026
767.1M · 12 analysts

Team and board

Officers

OfficerRole
Waleed HassaneinPresident and Chief Executive Officer
Fernando AraujoChief Financial Officer and Reiterates 2026 Financial Outlook
Anil RanganathSenior Vice President, General Counsel & Corporate Secretary
Miriam ProvostVice President of Global Regulatory Affairs
Nick CorcoranSenior Vice President of Supply Chain & Operations
Tamer KhayalChief Commercial Officer

Events

Calls

CallWhenStatus
TransMedics Group (NASDAQ:TMDX) Q3 2026 Earnings CallThu, Nov 05, 2026 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q2 2026 Earnings CallTue, Aug 04, 2026 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q1 2026 Earnings CallTue, May 05, 2026 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q4 2025 Earnings CallTue, Feb 24, 2026 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q3 2025 Earnings CallWed, Oct 29, 2025 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q2 2025 Earnings CallWed, Jul 30, 2025 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q1 2025 Earnings CallThu, May 08, 2025 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q4 2024 Earnings CallThu, Feb 27, 2025 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q3 2024 Earnings CallMon, Oct 28, 2024 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q2 2024 Earnings CallWed, Jul 31, 2024 · 4:30 PM ETReplay
All 24 calls
CallWhenStatus
TransMedics Group (NASDAQ:TMDX) Q1 2024 Earnings CallTue, Apr 30, 2024 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q4 2023 Earnings CallMon, Feb 26, 2024 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q3 2023 Earnings CallMon, Nov 06, 2023 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q2 2023 Earnings CallThu, Aug 03, 2023 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q1 2023 Earnings CallMon, May 01, 2023 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q4 2022 Earnings CallWed, Feb 22, 2023 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q3 2022 Earnings CallThu, Nov 03, 2022 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q2 2022 Earnings CallMon, Aug 01, 2022 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q1 2022 Earnings CallTue, May 03, 2022 · 5:00 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q4 2021 Earnings CallWed, Feb 23, 2022 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q2 2021 Earnings CallThu, Aug 05, 2021 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q1 2021 Earnings CallTue, May 04, 2021 · 4:30 PM ETReplay
TransMedics Group (NASDAQ:TMDX) Q3 2020 Earnings CallWed, Oct 21, 2020 · 5:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+27.9%
Q2 2026Aug 4, 2026 · After close−5.3%
Q1 2026May 5, 2026 · After close−23.2%
Q4 2025Feb 24, 2026−2.1%
Q3 2025Oct 29, 2025 · After close+1.1%
Q2 2025Jul 30, 2025 · After close+10.5%
Q1 2025May 8, 2025 · After close+19.6%
Q4 2024Feb 24, 2025 · After close−5.3%
Q3 2024Oct 28, 2024 · After close−29.9%
Q2 2024Jul 31, 2024 · After close+6.5%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 30, 2024 · After close+24.9%
Q4 2023Feb 26, 2024 · After close+14.1%
Q3 2023Nov 6, 2023 · After close+51.2%
Q2 2023Aug 3, 2023 · After close−8.3%
Q1 2023May 1, 2023 · After close−5.2%
Q4 2022Feb 22, 2023 · After close+20.6%
Q3 2022Nov 3, 2022 · After close+24.0%
Q2 2022Aug 1, 2022 · After close−10.3%
Q1 2022May 3, 2022 · After close+40.3%
Q4 2021Feb 23, 2022 · After close+30.1%

Open Events

Decks

DeckKindSlidesDate
Baird 2026 Global Healthcare ConferenceConference14 slidesSeptember 2026
Q2 2026 Earnings PresentationEarnings14 slidesAug 4, 2026
William Blair 2026Conference21 slidesJune 2026
Q1 2026 Earnings PresentationEarnings14 slidesMay 5, 2026
Q4 2025 Earnings PresentationEarnings9 slidesFeb 24, 2026
Q3 2025 Earnings PresentationEarnings9 slidesOct 29, 2025
Investor Presentation (January 2020)Investor deck24 slidesJan 13, 2020

Open Decks

IPO

Priced at US$16.00 a share on May 1, 2019.

Price
US$16.00 a share
Shares offered
5,690,000 shares of common stock
Offering size
US$91 million
Underwriters' option
Up to 853,500 more shares
Underwriters
MORGAN STANLEY, J.P. MORGAN, COWEN, CANACCORD GENUITY · In the order on the cover
Shares delivered
On or about May 6, 2019

Steps

StepWhen
Draft sent to the SEC in confidenceOct 19, 2018
Filed publiclyApr 5, 2019
Amended 3 timesNewest May 1, 2019
Shares registered with an exchangeMay 1, 2019
Declared effective by the SECMay 1, 2019
Final prospectus, with the priceMay 2, 2019

Open IPO · From the cover of the final prospectus (424B4) filed May 2, 2019

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue605.5M441.5M241.6M93.5M30.3M25.6M23.6M13.0M7.68M6.21M
Cost of revenue242.7M179.5M87.5M28.2M9.10M9.00M9.74M7.28M5.55M5.44M
Gross profit362.8M262.1M154.1M65.3M21.2M16.6M13.9M5.73M2.14M766.0K
Research and development69.1M56.0M36.1M26.8M22.3M18.8M19.9M13.7M15.0M15.6M
Selling, general and administrative185.2M168.6M119.6M69.9M38.3M24.2M23.6M12.3M7.61M8.12M
Operating income108.6M37.5M-28.7M-31.4M-39.4M-26.4M-29.6M-20.2M-20.4M-23.0M
Depreciation and amortization27.2M19.8M8.18M3.48M1.82M1.58M1.22M769.0K630.0K426.0K
EBITDA135.8M57.3M-20.6M-28.0M-37.6M-24.8M-28.4M-19.5M-19.8M-22.6M
Interest expense13.8M14.4M10.8M3.73M3.87M3.98M4.35M2.72M1.07M979.0K
Income before tax107.5M35.8M-26.7M-36.2M-44.2M-28.7M-33.5M-23.7M-20.8M-24.1M
Income tax-82.8M316.0K-1.64M66.0K36.0K0000984.0K
Net income190.3M35.5M-25.0M-36.2M-44.2M-28.7M-33.5M-23.8M-20.8M-24.1M
Earnings per share, basic5.601.07-0.77-1.23-1.60-1.16-2.36-17.48-0.98-1.66
Earnings per share, diluted4.871.01-0.77-1.23-1.60-1.16-2.36-17.48

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents488.4M336.6M394.8M201.2M25.6M24.6M20.1M20.2M12.4M9.84M
Short-term investments066.9M101.1M60.6M012.7M38.0M
Receivables84.3M97.7M63.6M27.6M5.93M6.86M6.56M3.44M925.0K1.38M
Inventory48.9M46.6M44.2M20.6M14.9M11.9M11.2M9.28M7.97M6.33M
Current assets637.8M497.2M510.7M252.3M118.7M146.8M100.0M34.8M34.0M55.9M
Property, plant and equipment327.7M286.0M173.9M19.2M9.84M4.75M4.79M3.47M2.46M1.72M
Goodwill11.5M11.5M12.0M0
Total assets1.07B804.1M706.0M277.1M134.9M152.0M105.3M42.2M37.0M58.1M
Accounts payable10.3M10.3M12.7M3.34M6.65M1.21M7.25M4.72M3.52M4.25M
Current liabilities89.3M59.9M54.9M23.7M23.2M11.9M16.1M12.6M10.9M9.47M
Long-term debt502.4M509.3M506.2M58.7M35.2M34.7M34.1M33.7M6.85M8.41M
Total debt10.0M518.3M515.9M58.7M35.2M34.7M34.1M33.7M8.65M8.41M
Total liabilities595.3M575.5M568.8M89.8M67.0M48.1M50.6M47.9M205.7M19.3M
Shareholders' equity473.1M228.6M137.2M187.4M67.9M103.9M54.6M-192.2M-168.7M38.8M
Shares outstanding34.3M33.6M32.7M32.1M27.8M27.2M21.2M1.40M21.2M14.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations192.8M48.8M-13.0M-45.8M-28.9M-30.3M-32.3M-26.0M-23.1M-24.1M
Capital spending-59.3M-129.7M-151.8M-11.9M-3.52M-455.0K-165.0K-418.0K-263.0K-1.48M
Free cash flow133.6M-80.9M-164.9M-57.7M-32.4M-30.7M-32.5M-26.4M-23.4M-25.6M
Cash from investing-59.3M-129.3M-194.0M54.5M29.3M-41.6M-60.5M12.3M24.9M-39.7M
Cash from financing16.9M22.9M400.4M167.9M1.39M75.5M92.7M22.1M3.00K63.5M
Dividends paid-51.1M-357.0K
Share buybacks-138.0K955.0K509.0K419.0K357.0K202.0K46.0K3.00K63.6M
Change in cash151.7M-58.2M193.6M175.6M999.0K4.49M-149.0K8.30M2.10M-243.0K

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 12, 2026Insider tradeSEC
144 · Notice of proposed saleNov 9, 2026Other filingsSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
4 · Change in ownershipOct 30, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 29, 2026Insider tradeSEC
4 · Change in ownershipSep 14, 2026Insider tradeSEC
8-K · Current reportSep 10, 2026Management or board changeSEC
4 · Change in ownershipAug 17, 2026Insider tradeSEC
10-Q · Quarterly reportAug 4, 2026Quarterly reportSEC
Show 200 filings
FilingDateTypeFiled with
8-K · Current reportAug 4, 2026ResultsSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 22, 2026Insider tradeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
8-K · Current reportMay 21, 2026Meeting outcomeSEC
DEFA14A · Additional proxy materialMay 7, 2026Meeting noticeSEC
10-Q · Quarterly reportMay 5, 2026Quarterly reportSEC
8-K · Current reportMay 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 10, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 10, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 10, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
3 · Initial statement of ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
8-K · Current reportFeb 27, 2026ResultsSEC
10-K · Annual reportFeb 24, 2026Annual reportSEC
8-K · Current reportFeb 24, 2026ResultsSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
3/A · Initial statement of ownership, amendedFeb 20, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 12, 2026Insider tradeSEC
8-K · Current reportFeb 4, 2026Management or board changeSEC
8-K · Current reportJan 12, 2026Material contractSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
144 · Notice of proposed saleDec 3, 2025Other filingsSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipOct 31, 2025Insider tradeSEC
10-Q · Quarterly reportOct 29, 2025Quarterly reportSEC
8-K · Current reportOct 29, 2025ResultsSEC
144 · Notice of proposed saleOct 29, 2025Other filingsSEC
8-K · Current reportOct 6, 2025Acquisition or disposalSEC
4 · Change in ownershipAug 8, 2025Insider tradeSEC
4 · Change in ownershipAug 5, 2025Insider tradeSEC
144 · Notice of proposed saleAug 4, 2025Other filingsSEC
10-Q · Quarterly reportJul 30, 2025Quarterly reportSEC
8-K · Current reportJul 30, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 18, 2025Big-stake noticeSEC
4 · Change in ownershipJun 10, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
144 · Notice of proposed saleMay 27, 2025Other filingsSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
4 · Change in ownershipMay 23, 2025Insider tradeSEC
144 · Notice of proposed saleMay 23, 2025Other filingsSEC
8-K · Current reportMay 23, 2025Meeting outcomeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
144 · Notice of proposed saleMay 9, 2025Other filingsSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
ARS · Annual report to shareholdersApr 10, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 10, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 10, 2025Meeting noticeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
144 · Notice of proposed saleMar 4, 2025Other filingsSEC
10-K · Annual reportFeb 27, 2025Annual reportSEC
8-K · Current reportFeb 27, 2025ResultsSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
8-K · Current reportFeb 21, 2025Acquisition or disposalSEC
8-K · Current reportJan 14, 2025Acquisition or disposalSEC
4 · Change in ownershipJan 10, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
8-K · Current reportDec 9, 2024Acquisition or disposalSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 6, 2024Big-stake noticeSEC
4 · Change in ownershipDec 4, 2024Insider tradeSEC
3 · Initial statement of ownershipDec 2, 2024Insider tradeSEC
8-K · Current reportDec 2, 2024Management or board changeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 7, 2024Insider tradeSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
144 · Notice of proposed saleNov 5, 2024Other filingsSEC
144 · Notice of proposed saleNov 1, 2024Other filingsSEC
10-Q · Quarterly reportOct 29, 2024Quarterly reportSEC
8-K · Current reportOct 28, 2024ResultsSEC
4 · Change in ownershipOct 17, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 7, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 7, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 4, 2024Big-stake noticeSEC
4 · Change in ownershipOct 3, 2024Insider tradeSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
8-K · Current reportSep 11, 2024Acquisition or disposalSEC
4 · Change in ownershipSep 5, 2024Insider tradeSEC
4 · Change in ownershipAug 29, 2024Insider tradeSEC
144 · Notice of proposed saleAug 27, 2024Other filingsSEC
4 · Change in ownershipAug 23, 2024Insider tradeSEC
144 · Notice of proposed saleAug 21, 2024Other filingsSEC
4 · Change in ownershipAug 19, 2024Insider tradeSEC
144 · Notice of proposed saleAug 15, 2024Other filingsSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
144 · Notice of proposed saleAug 8, 2024Other filingsSEC
144 · Notice of proposed saleAug 7, 2024Other filingsSEC
144 · Notice of proposed saleAug 6, 2024Other filingsSEC
4 · Change in ownershipAug 5, 2024Insider tradeSEC
10-Q · Quarterly reportAug 1, 2024Quarterly reportSEC
144 · Notice of proposed saleAug 1, 2024Other filingsSEC
8-K · Current reportJul 31, 2024ResultsSEC
8-K · Current reportJul 29, 2024Acquisition or disposalSEC
4 · Change in ownershipJul 17, 2024Insider tradeSEC
4 · Change in ownershipJul 3, 2024Insider tradeSEC
8-K · Current reportJul 2, 2024Acquisition or disposalSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
144 · Notice of proposed saleJun 5, 2024Other filingsSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
144 · Notice of proposed saleJun 3, 2024Other filingsSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
4 · Change in ownershipMay 31, 2024Insider tradeSEC
144 · Notice of proposed saleMay 29, 2024Other filingsSEC
144 · Notice of proposed saleMay 29, 2024Other filingsSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
4 · Change in ownershipMay 28, 2024Insider tradeSEC
8-K · Current reportMay 28, 2024Meeting outcomeSEC
4 · Change in ownershipMay 17, 2024Insider tradeSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
4/A · Change in ownership, amendedMay 14, 2024Insider tradeSEC
4/A · Change in ownership, amendedMay 14, 2024Insider tradeSEC
144 · Notice of proposed saleMay 10, 2024Other filingsSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 8, 2024Insider tradeSEC
4 · Change in ownershipMay 7, 2024Insider tradeSEC
144 · Notice of proposed saleMay 7, 2024Other filingsSEC
144 · Notice of proposed saleMay 6, 2024Other filingsSEC
144 · Notice of proposed saleMay 6, 2024Other filingsSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
144 · Notice of proposed saleMay 2, 2024Other filingsSEC
10-Q · Quarterly reportMay 2, 2024Quarterly reportSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
8-K · Current reportApr 30, 2024ResultsSEC
4 · Change in ownershipApr 18, 2024Insider tradeSEC
4 · Change in ownershipApr 12, 2024Insider tradeSEC
4 · Change in ownershipApr 10, 2024Insider tradeSEC
144 · Notice of proposed saleApr 10, 2024Other filingsSEC
ARS · Annual report to shareholdersApr 10, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 10, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 10, 2024Meeting noticeSEC
144 · Notice of proposed saleApr 8, 2024Other filingsSEC
4 · Change in ownershipApr 5, 2024Insider tradeSEC
144 · Notice of proposed saleApr 3, 2024Other filingsSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
144 · Notice of proposed saleApr 1, 2024Other filingsSEC
144 · Notice of proposed saleMar 18, 2024Other filingsSEC

This page holds 200 of 632 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from TransMedics Group, Inc.’s releases · as of Nov 2, 2026

Common shares
34,733,883
Fully diluted
34,733,883

Fully diluted

LineSharesAs of
Common shares34,733,883Nov 2, 2026

Share count over time

CountShares
Nov 2, 202634,733,883

Open Cap table

Shareholders

Institutions

HolderSharesValueChange vs Jun 30Filed
BlackRock5.49MUS$458M−106KNov 13, 2026
Fidelity5.17MUS$431M+35,541Nov 10, 2026
Vanguard3.63MUS$303M−108KNov 16, 2026
State Street1.43MUS$119M+5,041Nov 12, 2026
Goldman Sachs920KUS$76.7M+360KNov 16, 2026
Nomura893KUS$74.5M−17,361Nov 16, 2026
Geode Capital889KUS$74.2M−6,223Nov 6, 2026
Barrow Hanley Mewhinney & Strauss LLC838KUS$69.9MNewNov 12, 2026
Hood River Capital Management LLC767KUS$64M+15,722Nov 16, 2026
Eventide Asset Management, LLC683KUS$57M+134KNov 13, 2026
Show 50 holders
HolderSharesValueChange vs Jun 30Filed
Braidwell LP654KUS$54.6M+44,463Nov 16, 2026
Citadel646KUS$53.9M+86,829Nov 16, 2026
Dimensional628KUS$52.4M+17,877Nov 4, 2026
UBS587KUS$49M−300KNov 16, 2026
Wellington508KUS$42.4M−8,213Nov 16, 2026
Emerald Advisers, LLC493KUS$41.1M+2,535Nov 9, 2026
Morgan Stanley481KUS$40.1M+75,564Nov 13, 2026
BNP Paribas411KUS$34.3M+314KNov 12, 2026
Capital Group385KUS$32.1MNo changeNov 12, 2026
Principal373KUS$31.1M+132KNov 2, 2026
Northern Trust367KUS$30.7M−1,551Nov 16, 2026
Schwab348KUS$29M+19,053Nov 16, 2026
Bank of America338KUS$28.2M+81,124Nov 16, 2026
Wasatch Advisors LP333KUS$27.8M+24,728Oct 13, 2026
Barclays333KUS$27.8M+94,984Nov 6, 2026
Emerald Mutual Fund Advisers Trust311KUS$25.9M+8,853Nov 9, 2026
Hrt Financial LP290KUS$24.2M+125KNov 13, 2026
Tidal Investments LLC289KUS$24.2M+38,209Nov 13, 2026
Zevenbergen Capital Investments LLC267KUS$22.3M−41,109Oct 8, 2026
Baillie Gifford & Co259KUS$21.6M−8,815Nov 9, 2026
Congress Asset Management Co253KUS$21.1M+25,118Oct 6, 2026
Wells Fargo251KUS$20.9M−9,559Nov 16, 2026
DWS222KUS$18.5M+4,539Nov 6, 2026
Balyasny Asset Management L.P.209KUS$17.5MNewNov 16, 2026
JPMorgan200KUS$17M+7,708Nov 12, 2026
Longaeva Partners L.P.200KUS$16.7MNewNov 16, 2026
BNY192KUS$16M−2,080Nov 5, 2026
Davidson Kempner Capital Management LP167KUS$13.9MNo changeNov 16, 2026
Portolan Capital Management, LLC167KUS$13.9M+84,474Nov 16, 2026
Frontier Capital Management Co LLC163KUS$13.6M+12,776Nov 16, 2026
Public Sector Pension Investment Board155KUS$12.3M+35,902Nov 10, 2026
Millennium149KUS$12.4M−99,373Nov 16, 2026
Trek Financial, LLC144KUS$12MNewOct 29, 2026
ExodusPoint Capital Management, LP128KUS$10.7M+120KNov 16, 2026
Susquehanna114KUS$9.55M−141KNov 16, 2026
Oppenheimer & Co Inc107KUS$8.93M−3,711Oct 26, 2026
Renaissance Group LLC105KUS$8.74M−3,432Nov 12, 2026
Citigroup Inc103KUS$8.59M−283KNov 4, 2026
Bellevue Group AG101KUS$8.44MNo changeNov 16, 2026
Trexquant Investment LP100KUS$8.38M+6,457Nov 16, 2026

This page holds 50 of 376 holders. Open Shareholders

Funds

HolderSharesValueChangeAs of
iShares Core S&P Small-Cap ETF2.08MUS$138M+30,483Jun 30, 2026
Vanguard Total Stock Market Index Fund1.04MUS$69M+2,153Jun 30, 2026
iShares Russell 2000 ETF891KUS$59.2M+70,569Jun 30, 2026
Vanguard Small-Cap Index Fund752KUS$50M+832Jun 30, 2026
Fidelity Small Cap Growth Fund726KUS$55.6M+105KJul 31, 2026
Nomura Small Cap Core Fund617KUS$41.5M+144KMay 29, 2026
Fidelity Advisor New Insights Fund614KUS$40.8MNo changeJun 30, 2026
VIP Contrafund Portfolio590KUS$39.2MNo changeJun 30, 2026
Eventide Gilead Fund461KUS$30.6MNo changeJun 30, 2026
Vanguard Small-Cap Growth Index Fund435KUS$28.9M+14,919Jun 30, 2026
Show 50 holders
HolderSharesValueChangeAs of
Vanguard Extended Market Index Fund398KUS$26.4M+16,470Jun 30, 2026
VIP Mid Cap Portfolio384KUS$25.5MNo changeJun 30, 2026
Fidelity Small Cap Index Fund375KUS$28.7M+42,864Jul 31, 2026
SMALLCAP World Fund Inc374KUS$24.9MNo changeJun 30, 2026
Fidelity Small Cap Growth K6 Fund370KUS$28.3M+54,261Jul 31, 2026
Hood River Small-Cap Growth Fund365KUS$24.3MNo changeJun 30, 2026
Fidelity OTC Portfolio364KUS$27.8MNo changeJul 31, 2026
Fidelity Series Opportunistic Insights Fund344KUS$22.8MNo changeJun 30, 2026
Invesco S&P SmallCap Momentum ETF334KUS$25.6M+67,839Jul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF318KUS$21.1M+8,660Jun 30, 2026
iShares Russell 2000 Growth ETF317KUS$21M+42,230Jun 30, 2026
iShares S&P Small-Cap 600 Growth ETF311KUS$20.7M+16,068Jun 30, 2026
YieldMax(R) Ultra Option Income Strategy ETF250KUS$19.1M+100KJul 31, 2026
American Beacon Small Cap Value Fund229KUS$17.5MNewJul 31, 2026
Vanguard Tax-Managed Small-Cap Fund216KUS$14.3MNo changeJun 30, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF199KUS$13.2M+18,371Jun 30, 2026
Fidelity Extended Market Index Fund177KUS$11.9M−2,648May 31, 2026
Fidelity Stock Selector Small Cap Fund174KUS$13.3M+81,154Jul 31, 2026
Vanguard Russell 2000 Index Fund173KUS$11.6M+6,136May 31, 2026
Schwab U.S. Small-Cap ETF165KUS$11.1M−902May 31, 2026
iShares U.S. Medical Devices ETF162KUS$10.7M+14,604Jun 30, 2026
U.S. Small Cap Portfolio144KUS$11M+16,182Jul 31, 2026
Emerald Growth Fund133KUS$10.2MFirst reportJul 31, 2026
Fidelity Series Small Cap Opportunities Fund126KUS$9.66M+52,500Jul 31, 2026
SmallCap Growth Fund I121KUS$9.27M+58,062Jul 31, 2026
Vanguard S&P Small-Cap 600 Index Fund118KUS$7.95M+1,128May 31, 2026
Wasatch Small Cap Growth Fund113KUS$7.48M−25,491Jun 30, 2026
Dimensional U.S. Small Cap ETF111KUS$8.52M+18,776Jul 31, 2026
Fidelity Trend Fund102KUS$6.79M−7,100Jun 30, 2026
Vanguard Health Care Index Fund97,276US$6.54M+44May 31, 2026
U.S. Micro Cap Portfolio95,638US$7.32M+14,722Jul 31, 2026
Congress SMid Growth ETF95,152US$7.28M+840Jul 31, 2026
Fidelity Growth Strategies Fund91,354US$6.14MNo changeMay 31, 2026
Fidelity Advisor Mid Cap II Fund89,500US$5.94M+10,300Jun 30, 2026
Nomura Small Cap Growth Fund84,362US$5.6M+26,764Jun 30, 2026
Schwab Small-Cap Index Fund83,444US$6.38M+9,847Jul 31, 2026
Eventide Healthcare & Life Sciences Fund82,628US$5.49MNo changeJun 30, 2026
Fidelity Small Cap Stock Fund81,810US$6.26M+27,643Jul 31, 2026
Fidelity Advisor Small Cap Fund81,200US$5.46MNo changeMay 31, 2026
Fidelity Disciplined Equity Fund81,000US$6.2MNo changeJul 31, 2026

This page holds 50 of 314 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Tobin James R
Director
Sale59USD 93.96US$5,544Nov 9, 2026
Tobin James R
Director
Sale4,000USD 94.98US$380KNov 9, 2026
Weill David
Director
Buy1,336USD 81.63US$109KSep 11, 2026
Gunderson Thomas J.
Director
Sale9,624USD 75.06US$722KJun 15, 2026

Big stakes

HolderStakeSharesDate
FMR LLC15.00%5.06MMar 31, 2025
BlackRock, Inc.14.60%4.96MJun 30, 2025
Vanguard Portfolio Management LLC5.68%1.95MMar 31, 2026
Vanguard Capital Management LLC5.06%1.74MMar 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Merilee Raines
Other companies: Ocular Therapeutix, Inc. (Director · Since at least Sep 20, 2021); Watts Water Technologies, Inc. (Director · Since at least Feb 7, 2011); Benchmark Electronics, Inc. (Director · May 18, 2018 – May 12, 2021 · Past); Affymetrix Inc (Director · Jan 12, 2015 – Mar 31, 2016 · Past); Aratana Therapeutics Inc (Director · Feb 5, 2014 – Jul 18, 2019 · Past); IDEXX Laboratories, Inc. (Executive VP & CFO · Jan 13, 2006 – Feb 25, 2013 · Past)
Director · Since at least Jan 1, 2021
Edwin M. Kania
Other companies: Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – May 16, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Jan 8, 2015 · Past); EXACT Sciences Corporation (Director · Jul 21, 2006 – Jul 20, 2009 · Past)
Director · Since at least May 1, 2019
James R. Tobin
Other companies: Lyra Therapeutics, Inc. (Lead Independent Director · Since at least Mar 4, 2022); Globus Medical, Inc. (Director · Since at least Jan 14, 2021); Oxford Immunotec Global PLC (Director · Mar 8, 2021 – Mar 8, 2021 · Past)
Director · Since at least Feb 9, 2021
Stephanie Lovell
Other companies: Cyclerion Therapeutics, Inc. (Director · Apr 1, 2019 – Jun 14, 2022 · Past)
Director · Since at least Mar 22, 2021
Thomas J. Gunderson
Other companies: Merit Medical Systems, Inc. (Member, Compensation, Talent Development Committee, Finance, Operating Committee · Since at least May 24, 2017)
Director · Since at least May 1, 2019
Anil RanganathSenior Vice President, General Counsel & Corporate Secretary · Since at least Jun 5, 2023
David WeillDirector · Since at least May 1, 2019
Edward M. BasileDirector · Since at least May 1, 2019
Fernando AraujoChief Financial Officer and Reiterates 2026 Financial Outlook · Since at least Sep 10, 2026
Gerardo HernandezChief Financial Officer · Since at least Dec 2, 2024
All 24 people
PersonSeat
Gerardo Hernandez OmanaUntil Sep 10, 2026 · Past
Giovanni CecereChief Commercial Officer · Since at least Mar 14, 2025
James GilbertDirector · May 1, 2019 – May 1, 2019 · Past
John F CareyVP of Operations · May 1, 2019 – Feb 1, 2023 · Past
John F SullivanVP of Quality & Engineering · May 1, 2019 – Aug 30, 2021 · Past
Laura DammeVP, Clinical Affairs · Aug 5, 2019 – Feb 20, 2023 · Past
Matthew S ForsythSee Remarks · Since at least Mar 9, 2026
Miriam ProvostVice President of Global Regulatory Affairs · Since at least May 1, 2019
Nicholas CorcoranSee remarks · Since at least Jan 23, 2023
Nick CorcoranSenior Vice President of Supply Chain & Operations · Since at least Jan 12, 2026
Rakesh P GodhaniChief Digital Officer · Aug 4, 2021 – Aug 4, 2021 · Past
Stephen GordonChief Financial Officer · May 1, 2019 – Jun 3, 2024 · Past
Tamer KhayalChief Commercial Officer · Since at least May 1, 2019
Waleed HassaneinPresident and Chief Executive Officer · Since at least May 1, 2019

Open People

Log in to ask 6ix AI your own questions about TransMedics Group, Inc.